Xie Tong-Xin, Aldape Kenneth D, Gong Weida, Kanzawa Takao, Suki Dima, Kondo Seiji, Lang Frederick, Ali-Osman Francis, Sawaya Raymond, Huang Suyun
Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Int J Oncol. 2008 Jul;33(1):5-15.
Focal necrosis is a key pathologic feature that distinguishes glioblastoma from lower grade glioma. The presence of necrosis in a glioblastoma could promote its rapid growth and clinical progression. Focal necrosis of glioblastoma seems to be associated with thrombosis that result from hyper-coagulability. In the present study, we found that glioblastoma cells had a high level of constitutive nuclear factor (NF)-kappaB activity, which was directly correlated with necrosis in glioblastomas. We also found a direct correlation between NF-kappaB activity and the expression of tissue factor (TF), a potent procoagulant factor in gliomas. Inhibition of TF by an inhibitory antibody prevented the procoagulant activity of glioblastoma cells, indicating a TF-dependent mechanism. Blockade of NF-kappaB activation significantly inhibited TF expression and the procoagulant activity of glioblastoma cells in vitro. Blockade of NF-kappaB activation also significantly inhibited in vivo expression of TF, which was directly correlated with decreased necrosis formation and tumor growth of glioblastoma cells in nude mice. Collectively, these results suggest that elevated NF-kappaB activity in glioblastomas cells plays a critical role in necrosis formation of glioblastoma and that inhibition of NF-kappaB activity in glioblastoma can suppress necrosis formation and progressive growth.
局灶性坏死是区分胶质母细胞瘤与低级别胶质瘤的关键病理特征。胶质母细胞瘤中坏死的存在可促进其快速生长和临床进展。胶质母细胞瘤的局灶性坏死似乎与高凝状态导致的血栓形成有关。在本研究中,我们发现胶质母细胞瘤细胞具有高水平的组成型核因子(NF)-κB活性,这与胶质母细胞瘤中的坏死直接相关。我们还发现NF-κB活性与组织因子(TF)的表达之间存在直接关联,TF是胶质瘤中一种强效的促凝血因子。用抑制性抗体抑制TF可阻止胶质母细胞瘤细胞的促凝血活性,表明存在一种依赖TF的机制。在体外,阻断NF-κB激活可显著抑制TF表达和胶质母细胞瘤细胞的促凝血活性。阻断NF-κB激活还可显著抑制TF在体内的表达,这与裸鼠中胶质母细胞瘤细胞坏死形成减少和肿瘤生长直接相关。总体而言,这些结果表明胶质母细胞瘤细胞中NF-κB活性升高在胶质母细胞瘤坏死形成中起关键作用,并且抑制胶质母细胞瘤中的NF-κB活性可抑制坏死形成和肿瘤的进行性生长。